CCL2 shapes macrophage polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-dependent gene expression profile

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3858-3867

  Sierra Filardi, Elena ^a   Nieto, Concha ^a   Domínguez Soto, Ángeles ^a   Barroso, Rubén ^b   Sánchez Mateos, Paloma ^c   Puig Kroger, Amaya ^c   López Bravo, María ^b   Joven, Jorge ^d   Ardavín, Carlos ^b   Rodríguez Fernández, José L ^a   Sánchez Torres, Carmen ^e   Mellado, Mario ^b   Corbí, Ángel L ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVINS; ANIMALS; CHEMOKINE CCL2; CHEMOKINE CCL8; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, KNOCKOUT; MONOCYTES; RECEPTORS, CCR2; TRANSCRIPTOME;

EID: 84898622781     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302821     Document Type: Article

References (76)

1. Chow, A., B. D. Brown, and M. Merad. 2011. Studying the mononuclear phagocyte system in the molecular age. Nat. Rev. Immunol. 11: 788-798.
2. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
3. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
4. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
5. Akagawa, K. S. 2002. Functional heterogeneity of colony-stimulating factorinduced human monocyte-derived macrophages. Int. J. Hematol. 76: 27-34.
6. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 101: 4560-4565.
7. Verreck, F. A., T. de Boer, D. M. Langenberg, L. van der Zanden, and T. H. Ottenhoff. 2006. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γamma-and CD40L-mediated costimulation. J. Leukoc. Biol. 79: 285-293.
8. Li, G., Y. J. Kim, and H. E. Broxmeyer. 2005. Macrophage colony-stimulating factor drives cord blood monocyte differentiation into IL-10(high)IL-12absent dendritic cells with tolerogenic potential. J. Immunol. 174: 4706-4717.
9. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
10. Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, J. Kuratsu, and E. J. Leonard. 1989. Purification and amino acid analysis of two human gliomaderived monocyte chemoattractants. J. Exp. Med. 169: 1449-1459.
11. Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169: 1485-1490.
12. Proost, P., A. Wuyts, and J. Van Damme. 1996. Human monocyte chemotactic proteins-2 and-3: structural and functional comparison with MCP-1. J. Leukoc. Biol. 59: 67-74.
13. Berkhout, T. A., H. M. Sarau, K. Moores, J. R. White, N. Elshourbagy, E. Appelbaum, R. J. Reape, M. Brawner, J.Makwana, J. J. Foley, et al. 1997. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J. Biol. Chem. 272: 16404-16413.
14. Ajuebor, M. N., R. J. Flower, R. Hannon, M. Christie, K. Bowers, A. Verity, and M. Perretti. 1998. Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J. Leukoc. Biol. 63: 108-116.
15. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91: 3652-3656.
16. Weber, K. S., P. von Hundelshausen, I. Clark-Lewis, P. C. Weber, and C. Weber. 1999. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur. J. Immunol. 29: 700-712.
17. Kumar, S. N., and J. M. Boss. 2000. Site A of the MCP-1 distal regulatory region functions as a transcriptional modulator through the transcription factor NF1. Mol. Immunol. 37: 623-632.
18. Barna, B. P., J. Pettay, G. H. Barnett, P. Zhou, K. Iwasaki, and M. L. Estes. 1994. Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. J. Neuroimmunol. 50: 101-107.
19. Brown, Z., R. M. Strieter, G. H. Neild, R. C. Thompson, S. L. Kunkel, and J. Westwick. 1992. IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int. 42: 95-101.
20. Cushing, S. D., J. A. Berliner, A. J. Valente, M. C. Territo, M. Navab, F. Parhami, R. Gerrity, C. J. Schwartz, and A. M. Fogelman. 1990.Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87: 5134-5138.
21. Huber, J., F. W. Kiefer, M. Zeyda, B. Ludvik, G. R. Silberhumer, G. Prager, G. J. Zlabinger, and T. M. Stulnig. 2008. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J. Clin. Endocrinol. Metab. 93: 3215-3221.
22. Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, and E. J. Leonard. 1989. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 142: 1956-1962.
23. Suzuki, H. I., M. Arase, H. Matsuyama, Y. L. Choi, T. Ueno, H. Mano, K. Sugimoto, and K. Miyazono. 2011. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol. Cell 44: 424-436.
24. Liang, J., J. Wang, A. Azfer, W. Song, G. Tromp, P. E. Kolattukudy, and M. Fu. 2008. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J. Biol. Chem. 283: 6337-6346.
25. Matsushita, K., O. Takeuchi, D. M. Standley, Y. Kumagai, T. Kawagoe, T. Miyake, T. Satoh, H. Kato, T. Tsujimura, H. Nakamura, and S. Akira. 2009. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458: 1185-1190.
26. Gu, L.,S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins. 2000. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
27. Deshmane, S. L., S. Kremlev, S. Amini, and B. E. Sawaya. 2009. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29: 313-326.
28. O'Hayre, M., C. L. Salanga, T. M. Handel, and S. J. Allen. 2008. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem. J. 409: 635-649.
29. Roca, H., Z. S. Varsos, S. Sud, M. J. Craig, C. Ying, and K. J. Pienta. 2009. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J. Biol. Chem. 284: 34342-34354.
30. Chen, M., J. V. Forrester, and H. Xu. 2011. Dysregulation in retinal parainflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS ONE 6: e22818.
31. van Zoelen, M. A., M. I. Verstege, C. Draing, R. de Beer, C. van't Veer, S. Florquin, P. Bresser, J. S. van der Zee, A. A. te Velde, S. von Aulock, and T. van der Poll. 2011. Endogenous MCP-1 promotes lung inflammation induced by LPS and LTA. Mol. Immunol. 48: 1468-1476.
32. Zhang, T., R. Somasundaram, K. Berencsi, L. Caputo, P. Gimotty, P. Rani, D. Guerry, R. Swoboda, and D. Herlyn. 2006. Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4. Eur. J. Immunol. 36: 457-467.
33. Ishida, T., and R. Ueda. 2006. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci. 97: 1139-1146.
34. Charo, I. F., S. J. Myers, A. Herman, C. Franci, A. J. Connolly, and S. R. Coughlin. 1994. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91: 2752-2756.
35. Tanaka, S., S. R. Green, and O. Quehenberger. 2002. Differential expression of the isoforms for the monocyte chemoattractant protein-1 receptor, CCR2, in monocytes. Biochem. Biophys. Res. Commun. 290: 73-80.
36. Fleetwood, A. J., T. Lawrence, J. A. Hamilton, and A. D. Cook. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSFdependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178: 5245-5252.
37. Fleetwood, A. J., H. Dinh, A. D. Cook, P. J. Hertzog, and J. A. Hamilton. 2009. GM-CSF-and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J. Leukoc. Biol. 86: 411-421.
38. Sierra-Filardi, E., A. Puig-Kröger, F. J. Blanco, C. Nieto, R. Bragado, M. I. Palomero, C. Bernabéu, M. A. Vega, and A. L. Corbí. 2011. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117: 5092-5101.
39. Puig-Kröger, A., E. Sierra-Filardi, A. Domínguez-Soto, R. Samaniego, M. T. Corcuera, F. Gómez-Aguado, M. Ratnam, P. Sánchez-Mateos, and A. L. Corbí. 2009. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res. 69: 9395-9403.
40. Weber, C., K. U. Belge, P. von Hundelshausen, G. Draude, B. Steppich, M. Mack, M. Frankenberger, K. S. Weber, and H. W. Ziegler-Heitbrock. 2000. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67: 699-704.
41. Tacke, F., and G. J. Randolph. 2006. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609-618.
42. Moore, U. M., J. M. Kaplow, R. D. Pleass, S. W. Castro, K. Naik, C. N. Lynch, S. Daly, A. G. Roach, M. Jaye, and R. J. Williams. 1997. Monocyte chemoattractant protein-2 is a potent agonist of CCR2B. J. Leukoc. Biol. 62: 911-915.
43. Mantovani, A., T. Schioppa, C. Porta, P. Allavena, and A. Sica. 2006. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 25: 315-322.
44. Bottazzi, B., N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona, and A. Mantovani. 1983. Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 210-212.
45. Negus, R. P., G. W. Stamp, J. Hadley, and F. R. Balkwill. 1997. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150: 1723-1734.
46. Negus, R. P., G. W. Stamp, M. G. Relf, F. Burke, S. T. Malik, S. Bernasconi, P. Allavena, S. Sozzani, A. Mantovani, and F. R. Balkwill. 1995. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 95: 2391-2396.
47. Sica, A., A. Saccani, B. Bottazzi, S. Bernasconi, P. Allavena, B. Gaetano, F. Fei, G. LaRosa, C. Scotton, F. Balkwill, and A. Mantovani. 2000. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma. J. Immunol. 164: 733-738.
48. Inman, G. J., F. J. Nicolás, J. F. Callahan, J. D. Harling, L. M. Gaster, A. D. Reith, N. J. Laping, and C. S. Hill. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62: 65-74.
49. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur. J. Immunol. 25: 64-68.
50. Needham, M., N. Sturgess, G. Cerillo, I. Green, H. Warburton, R. Wilson, L. Martin, D. Barratt, M. Anderson, C. Reilly, and M. Hollis. 1996. Monocyte chemoattractant protein-1: receptor interactions and calcium signaling mechanisms. J. Leukoc. Biol. 60: 793-803.
51. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15: 675-705.
52. Dubois, P. M., D. Palmer, M. L. Webb, J. A. Ledbetter, and R. A. Shapiro. 1996. Early signal transduction by the receptor to the chemokine monocyte chemotactic protein-1 in a murine T cell hybrid. J. Immunol. 156: 1356-1361.
53. Ashida, N., H. Arai, M. Yamasaki, and T. Kita. 2001. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J. Biol. Chem. 276: 16555-16560.
54. Zhou, L., A. Azfer, J. Niu, S. Graham, M. Choudhury, F. M. Adamski, C. Younce, P. F. Binkley, and P. E. Kolattukudy. 2006. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ. Res. 98: 1177-1185.
55. Spence, S., A. Fitzsimons, C. R. Boyd, J. Kessler, D. Fitzgerald, J. Elliott, J. N. Gabhann, S. Smith, A. Sica, E. Hams, et al. 2013. Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 38: 66-78.
56. Sorensen, T. L., R. M. Ransohoff, R. M. Strieter, and F. Sellebjerg. 2004. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur. J. Neurol. 11: 445-449.
57. Hayashida, K., T. Nanki, H. Girschick, S. Yavuz, T. Ochi, and P. E. Lipsky. 2001. Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res. 3: 118-126.
58. Kusano, K. F., K. Nakamura, H. Kusano, N. Nishii, K. Banba, T. Ikeda, K. Hashimoto, M. Yamamoto, H. Fujio, A. Miura, et al. 2004. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ. J. 68: 671-676.
59. Sartipy, P., and D. J. Loskutoff. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 100: 7265-7270.
60. Niu, J., and P. E. Kolattukudy. 2009. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. 117: 95-109.
61. Fridlender, Z. G., G. Buchlis, V. Kapoor, G. Cheng, J. Sun, S. Singhal, M. C. Crisanti, L. C. Wang, D. Heitjan, L. A. Snyder, and S. M. Albelda. 2010. CCL2 blockade augments cancer immunotherapy. [Published erratum appears in 2010 Cancer Res. 70: 2569.] Cancer Res. 70: 109-118.
62. Qian, B. Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L. R. Campion, E. A. Kaiser, L. A. Snyder, and J. W. Pollard. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225.
63. Zhang, J., Y. Lu, and K. J. Pienta. 2010. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J. Natl. Cancer Inst. 102: 522-528.
64. Valkovic, T., F. Dobrila, M. Melato, F. Sasso, C. Rizzardi, and N. Jonjic. 2002. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch. 440: 583-588.
65. Sato, K., J. Kuratsu, H. Takeshima, T. Yoshimura, and Y. Ushio. 1995. Expression of monocyte chemoattractant protein-1 in meningioma. J. Neurosurg. 82: 874-878.
66. Shi, C., and E. G. Pamer. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11: 762-774.
67. Sozzani, S., and T. Musso. 2011. The yin and yang of Activin A. Blood 117: 5013-5015.
68. Quinones, M. P., S. K. Ahuja, F. Jimenez, J. Schaefer, E. Garavito, A. Rao, G. Chenaux, R. L. Reddick, W. A. Kuziel, and S. S. Ahuja. 2004. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J. Clin. Invest. 113: 856-866.
69. Van Coillie, E., J. Van Damme, and G. Opdenakker. 1999. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 10: 61-86.
70. Spinale, F. G. 2007. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 87: 1285-1342.
71. Takeda, N., E. L. O'Dea, A. Doedens, J. W. Kim, A. Weidemann, C. Stockmann, M. Asagiri, M. C. Simon, A. Hoffmann, and R. S. Johnson. 2010. Differential activation and antagonistic function of HIF-alpha isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24: 491-501.
72. Serhan, C. N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6: 1191-1197.
73. Crown, S. E., Y. Yu, M. D. Sweeney, J. A. Leary, and T. M. Handel. 2006. Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J. Biol. Chem. 281: 25438-25446.
74. Nesmelova, I. V., Y. Sham, J. Gao, and K. H. Mayo. 2008. CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations. J. Biol. Chem. 283: 24155-24166.
75. Gouwy, M., S. Struyf, S. Noppen, E. Schutyser, J. Y. Springael, M. Parmentier, P. Proost, and J. Van Damme. 2008. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol. Pharmacol. 74: 485-495.
76. O'Boyle, G., J. G. Brain, J. A. Kirby, and S. Ali. 2007. Chemokine-mediated inflammation: identification of a possible regulatory role for CCR2. Mol. Immunol. 44: 1944-1953.